An analysis of electronic health records from over one million people with type 2 diabetes and no prior diagnosis of dementia found that semaglutide use was associated with a 40 to 70% reduced risk developing dementia over three years, depending on the comparator medication, with the greatest benefit seen when compared to insulin
The authors observed that treatment with NAC resulted in elevated levels of BDNF that promotes neuronal survival, differentiation, and synaptic plasticity
10.1007/s00441-023-03806-1 Cell Tissue Res
Enthesitis and dactylitis were improved with adalimumab relative to placebo in this trial, although the differences did not reach statistical significance
Cocoa lovers, this ones for you Enjoy the delicious blend of cocoa, chocolate malt & oat milk with Nutrabliss Trim Choco Malt
Collectively, this tri-peptide formulation provides a multifaceted approach to studying regeneration, inflammation resolution, and extracellular matrix restoration in preclinical models Cagrilintide/GLP-1 Blend 5+5mg Summary Description: Cagrilintide and semaglutide are two structurally unrelated peptide-based therapeutic agents (an amylin analogue and a glucagon-like peptide-1 (GLP-1) receptor agonist, respectively)
.jpg)
.2308070949550.jpg)
